The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

Discover key Q3 2025 earnings insights for Illumina, including raised outlook, NovaSeq X growth, and margin expansion.

Signios Biosciences ("Signios Bio"), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaboration with Illumina, announced the winners of the ...

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

In the study, researchers molecularly screened nearly 2,000 cancer patients and matched 14 percent into a study arm.

The company's multi-year strategy involves the rollout of new products and upgrades to existing ones that further strengthen its position.

Illumina is rated a BUY as it drives growth with AI, multiomics, and strategic acquisitions. Click here to read my earnings ...

US-based company is developing next-generation sequencers, using AI models in the Republic to speed up diagnostics and lower ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced innovations to its Revio and Vega platforms last week. The innovations are expected to lower sequencing costs, add ...

General Motors has confirmed that the next-generation Cadillac CT5 will be sold in the U.S. market. In addition, the automaker has also confirmed that the upcoming CT5 will feature an internal ...

Apple today announced the M5 chip, its next-generation chip for the MacBook Pro, iPad Pro, and Vision Pro. From Apple's press release: Built using third-generation 3-nanometer technology, M5 ...